Drug Shortage Report for NEUPRO
| Report ID | 224301 |
| Drug Identification Number | 02403943 |
| Brand name | NEUPRO |
| Common or Proper name | Neupro 8mg 30 PAT iRT CA |
| Company Name | UCB CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ROTIGOTINE |
| Strength(s) | 8MG |
| Dosage form(s) | PATCH |
| Route of administration | TRANSDERMAL TRANSDERMAL |
| Packaging size | 30 |
| ATC code | N04BC |
| ATC description | |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-04-02 |
| Actual start date | 2024-04-03 |
| Estimated end date | 2024-04-16 |
| Actual end date | 2024-04-04 |
| Shortage status | Resolved |
| Updated date | 2024-04-05 |
| Company comments | Shortage due to delay in review and lot release process. No QA event expected. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2201 BRISTOL CIRCLE OAKVILLE, ONTARIO CANADA L6H 0J8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-04-05 | English | Compare |
| v4 | 2024-04-04 | French | Compare |
| v3 | 2024-04-04 | English | Compare |
| v2 | 2024-04-04 | French | Compare |
| v1 | 2024-04-04 | English | Compare |
Showing 1 to 5 of 5